HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Male Breast Cancer

Male breast cancer is a rare but significant health concern that deserves attention. While breast cancer is often associated with women, men can also develop this condition. The incidence of male breast cancer is considerably lower than in women, accounting for less than 1% of all breast cancer cases. The risk factors for male breast cancer are somewhat similar to those in women, including advancing age, a family history of breast cancer, genetic mutations (such as BRCA2), hormonal imbalances, and radiation exposure. Men with a history of conditions like Klinefelter syndrome, liver disease, or obesity may also face an elevated risk. Symptoms of male breast cancer may include a lump or swelling in the breast, changes in the nipple, skin dimpling, or discharge from the nipple. It is essential for men to be aware of these signs and promptly consult a healthcare professional if they notice any unusual changes. Diagnosis typically involves a combination of physical examinations, imaging tests (like mammography), and biopsy to confirm the presence of cancerous cells. Treatment options for male breast cancer may include surgery, chemotherapy, radiation therapy, and hormone therapy, depending on the stage and characteristics of the cancer. Given the rarity of male breast cancer, awareness and education are crucial. Men should be proactive about their health, performing regular self-examinations and seeking medical attention if any concerning symptoms arise. Early detection and intervention significantly improve the chances of successful treatment. In conclusion, while male breast cancer is infrequent, it is essential to recognize that men can be affected by this disease. Increased awareness, timely screenings, and a proactive approach to healthcare can contribute to better outcomes for those diagnosed with male breast cancer.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp